Effect of Troglitazone on Fibrinolysis and Activated Coagulation in Patients With Non–Insulin-Dependent Diabetes Mellitus
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 12 (4) , 181-186
- https://doi.org/10.1016/s1056-8727(97)00109-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Thiazolidinediones in the treatment of insulin resistance and type II diabetesDiabetes, 1996
- Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stressDiabetes, 1995
- Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patientsDiabetes, 1994
- Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor?Heart, 1993
- Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groupsDiabetes Care, 1993
- Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients.Heart, 1993
- Insulin Therapy in Type 2 Diabetic Subjects Suppresses Plasminogen Activator Inhibitor (PAI‐1) Activity and Proinsulin‐like Molecules Independently of Glycaemic ControlDiabetic Medicine, 1993
- Dietary regulation of fibrinolytic factorsAtherosclerosis, 1990
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987